3SOF

Tried to shake out weak hand yesterday. The mm made the impression that the stock broke down. Many people may take stop-loss.

The stock reversed beautifullay yesterday. May go up to new high soon.

Quote from: shawFund on April 07, 2006, 03:06:28 AM
Tried to shake out weak hand yesterday. The mm made the impression that the stock broke down. Many people may take stop-loss.

The stock reversed beautifullay yesterday. May go up to new high soon.

The only problem with that shawfund is that volume did not rise so much on the shakeout day.. for now we will stick with our exit on close which helped a lot on that day 

--------------

update QDEL:

QDEL had broken its ascending trendline but has maintained most of its price rise.  A close above 13 would be a nice signal that QDEL wants higher.. otherwise our exit plan remains the same.

------
Position Started: bought QDEL @ 11.24 on 3/01/2006
Current Order Status: Hold
Exit: on close below 12
Target: n/a
------

update QDEL:

Unfortuantely QDEL broke below our hold area.  We are still up a bit on this stock so lets follow the plan and take it home.

------
Position: bought QDEL @ 11.24 on 3/01/2006
Order: Sell in the morning
------

A 'Pandemic' Now Declared, Focus Back on Swine Flu Stocks
On Friday June 12, 2009, 12:00 pm EDT

The H1N1 virus is officially a pandemic, and vaccine stocks are responding.

Swine flu stocks are up again today, with some extending weekly gains to more than 20%. A number of companies released good news to end the week. From small-cap players to multi-billion dollar giants, shares are up big on high volume. Novartis (NYSE: NVS) announced today that it will have a swine flu vaccine ready by this fall. Shares are up by 4% on the news.

On Thursday, the World Health Organization raised its alert level on the virus to "Phase 6," indicating that it has officially become a pandemic.

As a whole the Swine Flu and Bird Flu Stocks Index is up by 2.5%. It is now beating the S&P 500 by 35.5% over the last month.

Generex Biotechnology (NASDAQ: GNBT) is leading the Index today with 10% gains. The company was granted five new patents for its drug delivery systems. The patents were awarded in Canada, Australia, New Zealand, Brazil, and Lebanon. The stock is still in negative territory this week by -3%.

Sinovac Biotech (AMEX: SVA) is adding another 3% to its industry-leading 30% weekly rally. On Monday the company announced that it had begun production of a swine flu vaccine, and noted that it could produce up to 30 million doses per year.

Vical (NASDAQ: VICL) has fallen from earlier highs, and is now trading up fractionally. Thomas Weisel initiated coverage of the company today with an Overweight rating and a $5 price target. The analyst cited Vical's proprietary technology, strategic partnerships, and licensing agreements.

GlaxoSmithKline (NYSE: GSK) and Hemispherx Biopharma (AMEX: HEB) are both ahead by more than 4% today.

Pure Bioscience (NASDAQ: PURE) and AVI Biopharma (NASDAQ: AVII) are industry laggards today, falling by -3% and -6% respectively.

As of this writing the Swine Flu and Bird Flu Stocks Index is a top-three performing tickerspy Index over the last month, gaining 39.5%.

Investors can follow the Swine Flu and Bird Flu Stocks Index and view related performance charts and metrics at tickerspy.com.

Investors can follow the Swine Flu and Bird Flu Stocks Index and view related performance charts and metrics at tickerspy.com.
http://www.tickerspy.com/index/Swine-Flu-and-Bird-Flu-Stocks?refer=2028Y3